Haci Hasan Yeter
Overview
Explore the profile of Haci Hasan Yeter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Haberal G, Saglam A, Yildirim T, Yilmaz S, Yeter H
CEN Case Rep
. 2024 Jul;
PMID: 39060835
Kidney transplant recipients are at an increased risk of various infections due to immunosuppressive medications. Among them, fungal infections are associated with high mortality and morbidity. This report presents the...
3.
Ozarli I, Yeter H, Sener Y, Cebrailov C, Yildirim T, Yilmaz R
Hemodial Int
. 2024 Jun;
28(3):326-335.
PMID: 38923655
Introduction: Expanded hemodialysis (HDx) could provide clearance of larger middle-molecule uremic toxins. We compared the effect of hemodialysis with medium cut-off membranes and high-flux (HFHD) membranes regarding changes in inflammation...
4.
Yeter H, Levent M, Sahiner L, Yildirim T, Yilmaz R
Ther Apher Dial
. 2024 Jun;
28(6):904-911.
PMID: 38894556
Introduction: This study aims to examine the relationship between fluid overload, Vascular Endothelial Growth Factor C (VEGF-C), plasma Angiotensinogen (pAGT), and echocardiography findings in hemodialysis patients. Methods: This was a...
5.
Akcay O, Yeter H, Yuksel O, Guz G
Horm Metab Res
. 2024 May;
56(7):489-497.
PMID: 38740062
Kidney transplantation (KT) is the best option for patients with end-stage renal disease, but recipients still have legacy bone mineral disease from the pretransplant period, especially patients with severe secondary...
6.
Akcay O, Yeter H, Unsal Y, Yasar E, Gonen S, Derici U
Hum Immunol
. 2023 Feb;
84(4):272-277.
PMID: 36797091
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection could present in a clinical spectrum of varying severity. Human leukocyte antigen (HLA) is a crucial component of the viral antigen presentation pathway...
7.
Yeter H, Karacalik C, Eraslan E, Durantas H, Akcay O, Derici K, et al.
Int Urol Nephrol
. 2022 Dec;
55(5):1335-1342.
PMID: 36528841
Purpose: Major cardiovascular events (MACE) are the leading cause of mortality in patients with chronic kidney disease. Although hemodialysis (HD) and peritoneal dialysis (PD) are comparable in survival, patients with...
8.
Oguz E, Yeter H, Akcay O, Besli S, Selen T, Derici U, et al.
Hemodial Int
. 2022 Jan;
26(3):377-385.
PMID: 35001488
Introduction: The transmission risk of Severe Acute Respiratory Syndrome Coronavirus-2 virus infection is increased in maintenance hemodialysis (MHD) patients, and also the disease causes much higher mortality than the normal...
9.
Yeter H, Milan Manani S, Ronco C
Clin Kidney J
. 2021 Dec;
14(12):2483-2489.
PMID: 34938532
Remote patient management (RPM) programs are one of the most crucial innovations in the peritoneal dialysis (PD) field that have been developed in the last decade. RPM programs are associated...
10.
Aktepe O, Sahin T, Guner G, Guven D, Yeter H, Kurtulan O, et al.
Turk J Gastroenterol
. 2021 Dec;
32(12):1049-1056.
PMID: 34876395
Background: Thrombospondin type 1 domain-containing 7A (THSD7A) has emerged as a new potential molecular tool for multiple tumors since that THSD7A was detected to be expressed in various malignant tumor...